The α-Glucosidase I Inhibitor Castanospermine Alters Endothelial Cell Glycosylation, Prevents Angiogenesis, and Inhibits Tumor Growth

Cancer Research

Volumn 55, Issue 13, 1995, Pages 2920-2926

  Pili, Roberto ^a   Chang, Joan ^a   Partis, Richard A ^b   Mueller, Richard A ^b   Chrest, Francis J ^a   Passaniti, Antonino ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASTANOSPERMINE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER; ENDOTHELIUM CELL; GLYCOSYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ALPHA-GLUCOSIDASES; ANIMAL; CELL ADHESION; CELL AGGREGATION; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CHEMOTAXIS; ENDOTHELIUM; GLUCOSAMINE; GLYCOCONJUGATES; GLYCOSYLATION; GROWTH INHIBITORS; IN VITRO; INDOLIZINES; MICE; MICE, INBRED C57BL; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 0028981092     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. True, D. D., Singer, M. S., Laurence, A. L., and Rosen, S. D. Requirement for sialic acid on the endothelial ligand of a lymphocyte homing receptor. J. Cell Biol., III: 2757–2764, 1990.
2. Corail, I., Kerbel, R. S., and Dennis, J. W. Tumor cell surface β-1,4-linked galactose binds to lectin(s) on microvascular endothelial cells and contributes to organ colonization. J. Cell Biol., 111: 773–781, 1990.
3. Akiyama, S. K., Yamada, S. S., and Yamada, K. Analysis of the role of glycosylation of the human fibronectin receptor. J. Biol. Chem., 264: 18011–18018, 1989.
4. Barcellos-Hoff, M. H. Mammary epithelial reorganization on extracellular matrix is mediated by cell surface galactosyltransferase. Exp. Cell Res., 201: 225–234, 1992.
5. Kornfeld, R., and Kornfeld, S. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem., 54: 631–664, 1985.
6. Elbein, A. D. Glycosidase inhibitors: inhibitors of N-linked oligosaccharide processing. FASEB J., 5: 3055–3063, 1991.
7. Winchester, B., and Fleet, W. J. Amino-sugar glycosidase inhibitors: versatile tools for glycobiologists. Glycobiology, 2: 199–210, 1992.
8. Sunkara, P. S., Bowlin, T. L., Liu, P. S., and Sjoersma, A. Antiretroviral activity of castanospermine and deoxynojirimycin, specific inhibitors of glycoprotein processing. Biochem. Biophys. Res. Commun., 148: 206–210, 1987.
9. Ruprecht, R. M., Mullaney, S., Andersen, J., and Bronson, R. In vivo analysis of castanospermine, a candidate anti-retroviral agent. J. Acquired Immune Defic. Syndr., 2: 149–157, 1989.
10. Spearman, M. A., Ballon, J. M., Gerrard, J. M., Greenberg A. H., and Wright, J. A. TTie inhibition of platelet aggregation of metastatic H-ras-transformed 10T½ fibroblast with castanospermine, an N-linked glycoprotein processing inhibitor. Cancer Lett., 60: 185–191, 1991.
11. Humphries, M. J., Matsumoto, K., White, S. L., and Olden, K. Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors. Cancer Res., 46: 5215–5222,1986.
12. Hadwiger, A., Niemann, H., Kabish, A., Bauer, H., and Tamura, T. Appropriate glycosylation of the fms gene product is a prerequisite for its transforming potency. EMBO J., 5: 689–694, 1986.
13. Folkman, J. Toward an understanding of angiogenesis: search and discovery. Perspect. Biol. Med., 29: 10–36, 1985.
14. Folkman, J., and Klagsburn, M. Angiogenic factors. Science (Washington DC), 235: 442–447, 1987.
15. Risau, W., and Lemmon, V. Changes in the vasculature extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev. Biol., 725: 441–450, 1988.
16. Liotta, L. A., Steeg, P. S., and Stetler-Stevenson, W. G. Angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327–336, 1991.
17. Folkman, J., and Haudenschild, C. Angiogenesis in vitro. Nature (Lond.), 288: 551–556, 1980.
18. Maciag, T., Kadish, J., Wilkins, L., Sternerman, M. B., and Weinstein, R. Organizational behavior of human umbilical vein endothelial cells. J Cell Biol., 94: 511–520,1982.
19. Nicosia, R. F., and Madri, J. A. The microvascular extracellular matrix: developmental changes during angiogenesis in the aortic ring-plasma clot model. Am. J. Pathol., 128: 78–90, 1987.
20. Montesano, R., Orci, L., and Vassali, P. In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J. Cell Biol., 97: 1648–1652, 1983.
21. Ingber, D. E., and Folkman, J. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulating angiogenesis in vitro: role of extracellular matrix. J. Cell Biol., 109: 317–330, 1989.
22. Kubota, Y., Kleinman, H. K., Martin, G. R., and Lawley, T. J. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capiUary-like structures. J. Cell Biol., 107: 1589–1598, 1988.
23. Grant, D. S., Tashiro, K., Segui-ReaL., B., Yamada, Y., Martin, G. R., and Kleinman, H. K. Two different laminin domains mediate the differentiation of human endothelial cells into capUlary-like structures in vitro. Cell, 58: 933–943, 1989.
24. Kleinman, H. J., McGarvey, M. L., Hassel, J. R., Star, V. L., Cannon, F. B., Laurie, G. W., and Martin, G. R. Basement membrane complexes with biological activity. Biochemistry, 25: 312–318, 1986.
25. KinseUa, J. L., Grant, D. S., Weeks, B. S., and Kleinman, H. K. Protein kinase C regulates endothelial cell tube formation on basement membrane matrix, Matrigel. Exp. Cell Res., 199: 56–62, 1992.
26. Passaniti, A., Taylor, R. M., PUi, R., Guo, Y., Long, P. V., Haney, J. A., Pauly, R. R., Grant, D. S., and Martin, G. R. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest., 67: 519–528, 1992.
27. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55–63, 1983.
28. Denizot, F., and Lang, R. Rapid colorimetric assay for cell growth and survival. J. Immunol. Methods, 89: 211–271, 1986.
29. Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R., Aaronson, S. A., Kozlowski, J. M., and McEwan, R. N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47: 3239–3245, 1987.
30. Danielson, K. G., Martinez-Hernandez, A., Hassell, J. R., and Iozzo, R. V. Establishment of a cell line from the EHS tumor: biosynthesis of basement membrane constituents and characterization of a hybrid proteoglycan containing heparan and chondroitin sulfate chains. Matrix, 11: 22–35, 1992.
31. 3 for angiogenesis. Science (Washington DC), 264: 569–571, 1994.
32. Cummings, R. D., and Kornfeld, S. Characterization of the structural determinants for the high affinity interaction of asparagine-linked oligosaccharides with immobilized Pnaseolus vulgaris leukoagglutinating and erythroagglutinating lectins. J. Biol. Chem., 257: 11230–11234, 1982.
33. Lis, H., and Sharon, N. Lectins: their chemistry and application to immunology. In: M. Sela (ed.), The Antigens, Vol. IV, pp. 429–529. New York: Academic Press, 1977.
34. Iichtner, R. B., and Schirrmacher, V. Cellular distribution and biological activity of epidermal growth factor receptors in A431 cells are influenced by cell-cell contact. J. Cell. Physiol., 144: 303–312, 1990.
35. Rosen, S. D., Chi, S., True, D. D., Singer, M. S., and Yednock, T. A. Intravenously injected sialidase inactivates attachment sites for lymphocytes on high endothelial venules. J. Immunol., 142: 1895–1902, 1989.
36. Renkonen, R., and Ustinov, J. Carbohydrate synthesis inhibitors decrease interleukin 1-stimulated lymphocyte binding to endothelial cells. Eur. J. Immunol., 21: 777–781, 1991.
37. Elbein, A. D., Kerbacher, J. K., Schwartz, C. J., and Sprague, E. A. Kirunensine inhibits glycoprotein processing and the function of the modified LDL receptor in endothelial cells. Arch. Biochem. Biophys., 288: 177–184, 1991.
38. Barnathan, E. S., Kuo, A., Karikò, K., Roscnfeld, L., Murray, S. C., Behrendt, N., Ronne, E., Weiner, D., Henkin, J., and Cines, D. B. Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and messenger RNA. Blood, 76: 1795–1806, 1990.
39. Tiganis, T., Leaver, D. D., Ham, K., Friedhuber, A., Stewart, P., and Dziadek, M. Functional and morphological changes induced by tunicamycin in dividing and confluent endothelial cells. Exp. Cell Res., 198: 191–200, 1992.
40. Nguyen, M., Folkman, J., and Bischoff, J. 1-Deoxymannojirimycin inhibits capillary tube formation in vitro. J. Biol. Chem., 267: 26157–26165, 1992.
41. Nguyen, M., Strubel, N. A., and Bischoff, J. A role for sialyl Lewis-X/A glycocon-jugates in capillary morphogenesis. Nature (Lond.), 365: 267–269, 1993.
42. Ausprunk, D. H., Knighton, D. R., and Folkman, J. Differentiation of vascular endothelium in the chick chorioallantois: a structural and autoradiographic study. Dev. Biol., 38: 237–248, 1974.
43. Gimbrone, M. A., Jr., Cotran, R. S., and Folkman, J. Tumor growth and neovascularization: an experimental model using the rabbit cornea. J. Natl. Cancer Inst., 52: 413–427, 1974.
44. Kibbey, M. C., Grant, D. S., and Kleinman, H. K. Role of SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model. J. Natl. Cancer Inst, 84: 1633–1638, 1992.
45. Grant, D. S., KinseUa, J. L., Fridman, R., Auerbach, R., Piasecki, B. A., Yamada, Y., Zain, M., and Kleinman, H. K. Interaction of endothelial cells with a laminin A chain peptide (SIKVAV). J. Cell. Physiol., 153: 614–625, 1992.
46. Grant, D. S., Kleinman, H. K., Goldberg, I. D., Bhargava, M. M., Nickloff, B. J., KinseUa, J. L., Polvcrini, T., and Rosen, E. M. Scatter factor induces blood vessel formation in vivo. Proc. NaU. Acad. Sci. USA, 90: 1937–1941, 1993.
47. Vukanovic, J., Passaniti, A., Hirata, T., Traystman, R. J., Hartley-Asp, B., and Isaacs, J. T. Antiangiogenic effects of the quinoline-3-carboxamide linomide. Cancer Res., 53: 1833–1837, 1993.